Bacterial Cell Culture Global Market Report 2025

The bacterial cell culture market size has grown strongly in recent years. It will grow from $3.18 billion in 2024 to $3.44 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing demand for therapeutic proteins, rising prevalence of chronic diseases, expansion of biopharmaceutical manufacturing, growth in fermentation processes, and increasing research and development activities.

The bacterial cell culture market size is expected to see strong growth in the next few years. It will grow to $4.69 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth during the forecast period can be attributed to the surge in biopharmaceuticals, rising investment in cell and gene therapies, increasing adoption of personalized medicine, growing demand for bacterial culture systems, and expansion of contract manufacturing organizations. Key trends in the forecast period include automation of bacterial cell culture processes, integration of AI and data analytics, development of sustainable and cost-effective media, adoption of high-throughput screening techniques, and expansion of multi-regional manufacturing networks.

The rising incidence of infectious illnesses is expected to drive the growth of the bacterial cell culture market in the coming years. Infectious illnesses are caused by microorganisms such as bacteria, viruses, fungi, or parasites, which can transmit from one organism to another. The increase in these illnesses is fueled by global travel, which enables pathogens to spread quickly across previously isolated regions and populations. Bacterial cell culture supports infectious disease research by allowing scientists to grow and study bacteria in controlled environments, facilitating accurate identification and development of targeted treatments. For example, in October 2024, the Center for Infectious Disease Research and Policy, a US-based public organization, reported that the estimated total number of TB cases, including undiagnosed cases, rose to 10.8 million in 2023 from 10.7 million in 2022. Therefore, the rising incidence of infectious illnesses is boosting the bacterial cell culture market.

Leading companies in the bacterial cell culture market are focusing on automated culturing technologies to enhance research efficiency and precision. Automated culturing technology uses machines and software to grow and monitor microbial or cell cultures with minimal manual intervention, enabling high-throughput experiments. For instance, in September 2023, OGI Bio, a Scotland-based biotechnology company, launched the Mk2 Microbial Culturing System, the next-generation automated cell culturing platform. The Mk2 offers higher performance, improved functionality, and user-friendly operation for modern research labs. It allows precise monitoring of microbial growth, dissolved oxygen, and fluorescent signals, with the Turbidostat pump providing accurate control of these parameters. These innovations make the Mk2 a robust tool for advancing research in microbiology, biotechnology, and synthetic biology.

In April 2025, Sartorius, a Germany-based life sciences company, partnered with Mabion S.A. to advance biopharmaceutical development. The collaboration enables Sartorius and Mabion to deliver a complete suite of integrated biopharmaceutical development services. Sartorius focuses on lab-scale development, leveraging its expertise in cell culture media, cell line development, and upstream process optimization, while Mabion handles advanced upstream development, 10L bioreactor confirmation, downstream process optimization, analytics, validation, scale-up, and large-scale manufacturing. Mabion S.A. is a Poland-based contract development and manufacturing organization.

Major players in the bacterial cell culture market are Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, Avantor Inc., Cytiva, Sartorius AG, FUJIFILM Irvine Scientific, Bio-Techne Corporation, Repligen Corporation, Takara Bio Inc., Becton, Dickinson and Company, HiMedia Laboratories Pvt. Ltd., Capricorn Scientific GmbH, Athena Environmental Services Inc., Genexis Biotech Pvt. Ltd., BioProcess Technologies Ltd., Athena Medical Products Inc., and Jin Kairui Biotechnology Co. Ltd.

North America was the largest region in the bacterial cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bacterial cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The bacterial cell culture market research report is one of a series of new reports that provides bacterial cell culture market statistics, including bacterial cell culture industry global market size, regional shares, competitors with a bacterial cell culture market share, detailed bacterial cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial cell culture industry. This bacterial cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bacterial cell culture refers to the controlled cultivation of bacterial cells in a laboratory setting. It involves providing optimal conditions, including appropriate nutrients, temperature, and pH, to support bacterial growth and survival. This process allows for detailed study of bacterial behavior, physiology, and biological characteristics under consistent and reproducible conditions.

The primary product types for bacterial cell culture include media, reagents, sera, consumables, and others. Bacterial cell culture media is a nutrient-rich formulation designed to support the growth, maintenance, and proliferation of bacterial cells under controlled laboratory conditions. It is used for various bacterial types, including gram-positive bacteria, gram-negative bacteria, anaerobic bacteria, thermophilic bacteria, and others, and finds applications in disease diagnosis, food testing, water testing, biopharmaceutical production, research laboratories, and more. Key end-users include diagnostic centers, the food industry, and additional organizations.

The countries covered in the bacterial cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bacterial cell culture market consists of sales of agar plates, inoculating loops, petri dishes, centrifuges, and cryopreservation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.